CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 30, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 296,343	$ 174,938
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	104,518	103,350
Deferred income tax expense (benefit)	(10,958)	15,519
Stock-based compensation	7,023	4,744
Loan cost amortization	1,239	1,311
Loss on property disposals	900	1,842
Accretion of discount related to Senior Notes	608	649
Asset impairment	589	0
Gain on early extinguishment of debt recognized as a component of interest expense	(107)	0
Gain on equity-method investments	(1)	(2)
Changes in operating assets and liabilities:
Trade accounts and other receivables	(91,504)	72,350
Inventories	(64,233)	114,471
Prepaid expenses and other current assets	(44,021)	(27,628)
Accounts payable, accrued expenses and other current liabilities	(118,667)	(212,807)
Income taxes	51,887	35,797
Long-term pension and other postretirement obligations	(1,414)	(1,315)
Other operating assets and liabilities	(5,311)	(12,192)
Cash provided by operating activities	126,891	271,027
Cash flows from investing activities:
Acquisitions of property, plant and equipment	(98,274)	(108,429)
Proceeds from property disposals	1,185	2,217
Cash used in investing activities	(97,089)	(106,212)
Cash flows from financing activities:
Payments on revolving line of credit, long-term borrowings and finance lease obligations	(3,553)	(153)
Proceeds from contribution of capital under Tax Sharing Agreement between JBS USA Holdings and Pilgrim’s Pride Corporation	0	1,425
Payments of capitalized loan costs	0	(16)
Cash provided by (used in) financing activities	(3,553)	1,256
Effect of exchange rate changes on cash and cash equivalents	8,060	(2,411)
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents	34,309	163,660
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	2,043,158	731,223
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period	$ 2,077,467	$ 894,883